Roffman Miller Associates Inc. PA Buys 43,645 Shares of The Cigna Group (NYSE:CI)

Roffman Miller Associates Inc. PA boosted its stake in The Cigna Group (NYSE:CI - Free Report) by 2,536.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 45,366 shares of the health services provider's stock after acquiring an additional 43,645 shares during the quarter. Roffman Miller Associates Inc. PA's holdings in The Cigna Group were worth $15,717,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Checchi Capital Advisers LLC boosted its holdings in shares of The Cigna Group by 0.9% during the second quarter. Checchi Capital Advisers LLC now owns 3,584 shares of the health services provider's stock valued at $1,185,000 after acquiring an additional 31 shares during the period. Benjamin F. Edwards & Company Inc. boosted its stake in The Cigna Group by 1.4% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,206 shares of the health services provider's stock valued at $729,000 after purchasing an additional 31 shares during the period. IFG Advisors LLC grew its position in The Cigna Group by 4.6% in the 3rd quarter. IFG Advisors LLC now owns 699 shares of the health services provider's stock worth $242,000 after purchasing an additional 31 shares during the last quarter. McClarren Financial Advisors Inc. increased its stake in shares of The Cigna Group by 4.7% in the third quarter. McClarren Financial Advisors Inc. now owns 692 shares of the health services provider's stock valued at $240,000 after purchasing an additional 31 shares during the period. Finally, Saxony Capital Management LLC raised its holdings in shares of The Cigna Group by 5.3% during the second quarter. Saxony Capital Management LLC now owns 638 shares of the health services provider's stock valued at $211,000 after buying an additional 32 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company's stock.

The Cigna Group Price Performance

CI stock traded up $0.20 during mid-day trading on Monday, hitting $318.01. The stock had a trading volume of 1,155,539 shares, compared to its average volume of 1,542,493. The firm has a fifty day simple moving average of $331.01 and a 200 day simple moving average of $338.05. The firm has a market capitalization of $88.45 billion, a P/E ratio of 29.98, a P/E/G ratio of 0.96 and a beta of 0.50. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The Cigna Group has a 52 week low of $288.88 and a 52 week high of $370.83.

The Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, beating the consensus estimate of $7.22 by $0.29. The company had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The firm's revenue for the quarter was up 29.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.77 EPS. As a group, research analysts forecast that The Cigna Group will post 28.49 EPS for the current year.

The Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be issued a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a yield of 1.76%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group's dividend payout ratio is 52.83%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on CI. JPMorgan Chase & Co. upped their price target on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 21st. Barclays boosted their price target on The Cigna Group from $405.00 to $420.00 and gave the stock an "overweight" rating in a research report on Tuesday, November 5th. Piper Sandler restated an "overweight" rating and issued a $394.00 price objective (up from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. Royal Bank of Canada cut their price objective on The Cigna Group from $384.00 to $377.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $400.00 price objective on shares of The Cigna Group in a report on Wednesday, October 23rd. One research analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $394.64.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.